Prescribing for emotionally unstable personality disorder: clinicians’ views

Abstract

Emotionally unstable personality disorder (EUPD) has become a public health challenge due to its prevalence, cost to health care services and comorbidities. Prescribers are faced with a clinical conundrum when offering medication to patients with EUPD due to the risk of deliberate overdose. Here, the authors analyse clinicians’ views and experiences pertaining to prescribing medications for EUPD within the context of the NICE guidelines, with resulting messages to enable positive change in future clinical guidelines and policies.